Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Metastatic Migration in Cancer may be Influenced by Metabolism

Cutaneous Manifestations of Internal Malignancy

Cancer Pain

Cancer Classification

Insights into Oncofertility

Cancer Symptoms

What Causes Cancer?

Cancer Research

What is the Tumor Microenvironment?

Cancer Prognosis

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

See more featured articles »

CDK9 and Cancer

What is Immunochemotherapy?

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Hot vs Cold: the differences between tumor types

Assay for Monitoring and Treating Malignant Brain Tumors

Hypoxia Markers and Their Importance

Cancer Prevention: Lowering your Risk

Cancer Diagnosis

Using Biomarkers to Detect Cancer

The Effects of Cancer on Family Life

Secondary Brain Cancer

Cancer Epidemiology

Microfluidic cancer treatment screen combined with flow cytometry

Cancer History

Is Cancer a Metabolic Disorder?

Exploiting Enzymes in Cancer Diagnosis and Therapy

Secondary Lung Cancer

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Why are Cancer Cell Lines Useful?

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

What is Cancer?

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Myc Mutations and Cancer

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Investigating the Molecular Mechanisms of Cancer

The Biochemistry of Breast Cancer Screening

British Pioneers in Cancer Biology

Cancer Pathophysiology

Insight into Cancer Vaccines

What is Tumorigenesis?

Living with Cancer Pain

Extracellular Vesicles as Floating Cancer Biomarkers

What Role do Biobanks Play in Cancer Research?

Overview of Cell Viability and Cytotoxicity

Caring for a Loved One with Cancer

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

The Cancer Cell Surface Proteome as a Therapeutic Target

Transforming Cancer Care through Genomic Testing

Pediatric Cancer

Effects of Social and Economic Deprivation on Cancer Mortality

What is Merkel Cell Carcinoma?

Cancer Management

TARDIS: The Improved Method of Detecting Breast Cancer

Cancer Glossary

Cancer Pain Management

Cancer Screening Considerations: Balancing the Benefits and Risks

Targeted Cancer Therapies

What is Cancer of Unknown Primary?

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Acidosis and Tumor Progression

Latest Cancer News and Research

Organoid coculture platforms enhance preclinical prediction of drug efficacy

Three‐dimensional cancer organoids cultured in vitro closely recapitulate the phenotypic and genetic features of parental tumor tissues, making them powerful tools for cancer research, drug screening, and personalized medicine.

5 Nov 2026

Three-drug combination remodels immune environment in gastric cancer

A triplet combination therapy can remodel the tumor microenvironment in patients with advanced gastric cancer and shows a promising safety profile, according to results from a new phase 2 clinical trial.

5 Nov 2026

Women with DCIS may not need routine imaging after double mastectomy

Women who have undergone a double mastectomy to treat ductal carcinoma in situ (DCIS), a noninvasive form of breast cancer also known as stage 0 breast cancer, may not benefit from routine mammograms or other breast imaging after surgery, according to a new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center.

4 Nov 2026

A study of 27,000 adults links bean products and soy compounds to lower kidney disease odds

A cross-sectional study of 27,003 adults in Northeast China found that higher consumption of processed bean products and soy isoflavones was associated with lower odds of chronic kidney disease, while plain bean intake showed no significant association. The relationship with soy isoflavones was stronger in women, although the observational findings cannot establish whether these foods protect against kidney disease.

4 Nov 2026

Deep learning method maps spatial architecture of brain cancer cells

Glioblastoma is the deadliest and most common type of malignant brain tumour in adults. One of the reasons it's almost always incurable is that individual tumour cells are very different from one another and shift dynamically between various 'states'.

4 Nov 2026

Cannabis dominates youth hospital visits while alcohol impacts older adults

A large national study analyzing emergency department visits and hospitalizations related to alcohol or cannabis use across the U.S. has found diverging age patterns: Among people who presented to the hospital for a substance-related problem, cannabis was involved in the majority of visits by adolescents and young adults, while alcohol predominated among older adults.

4 Nov 2026

Protein DUSP4 prevents immune cell exhaustion in colorectal cancer

The immune system has powerful cells that can recognize and destroy cancer, but this ability can gradually wane when the cells reside within a tumor.

4 Nov 2026

Researchers develop method to generate billions of cDC1 immune cells

Conventional type 1 dendritic cells, known as cDC1 cells, are immune cells that help initiate responses against intracellular pathogens and tumors.

4 Nov 2026

Rutgers-led team secures $6.5 million grant for lung cancer research

A Rutgers-led consortium has been awarded a $6.5 million grant from the National Cancer Institute (NCI) to support next-generation tools to guide tobacco control policies, improve lung cancer screening, strengthen survivorship care, and support state-level cancer prevention planning.

3 Nov 2026

AlphaFold3 reveals molecular interactions driving T cell recognition

Researchers at the Translational Genomics Research Institute (TGen), part of City of Hope, have developed a new approach using the artificial intelligence platform AlphaFold3 to predict whether a T cell receptor will recognize a specific antigen based solely on its genetic sequence.

3 Nov 2026

Engineered beneficial bacteria reduce bloodstream infections after stem cell transplants

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the country, and collaborators have pioneered a new approach to preventing dangerous bloodstream infections in patients receiving donor stem cell transplants for blood cancers.

3 Nov 2026

Synthetic DNA molecules enable precise targeting of cancer-linked genes

Researchers have developed a promising new approach that uses synthetic DNA molecules to target cancer-linked genes directly, opening new possibilities for future treatments, diagnostics and biological research.

3 Nov 2026

Blood may reveal signs of gut-related disease that stool samples miss

In a study of 193 participants, researchers found that blood-based short-chain fatty acid profiles distinguished colorectal cancer, celiac disease, obesity, and healthy controls with 95% accuracy, compared with 59% for stool-based measurements. Combining blood and stool profiles increased accuracy to 97%, suggesting that circulating microbial metabolites may offer valuable diagnostic information, although larger studies are needed to validate the findings.

3 Nov 2026

Vanderbilt researchers create massive transcriptomic atlas of breast cancer

A new molecular map of breast cancer has identified novel forms of the disease and provides a foundation for selecting personalized treatments guided by a tumor's molecular characteristics rather than standard pathology alone.

3 Nov 2026

Advanced imaging tool improves detection of residual multiple myeloma disease

A targeted immunoPET scan detected active multiple myeloma that standard PET/CT scans and blood tests missed, a finding that could help doctors more accurately map disease, guide treatment decisions and confirm whether cancer remains after therapy.

3 Nov 2026

Spaceflight research opens new avenues for studying rare pediatric diseases

Earth-based hiPSC models have transformed disease research but remain limited by cellular immaturity, a strong reliance on glycolysis rather than oxidative phosphorylation (OXPHOS), and incomplete tissue architecture.

3 Nov 2026

Immune cell neighborhoods control cancer spread and metastasis formation

Published in Nature Cancer: Researchers at the Université libre de Bruxelles (ULB) have discovered that immune cells build distinct "neighborhoods" around cancer cells.

3 Nov 2026

First Medicare ExRad study reveals wide variation in CT radiation

The first study to examine how imaging facilities perform on the new Medicare "ExRad" measure shows that radiation doses used for the same type of CT scan vary widely from one facility to the next.

3 Nov 2026

Study identifies new target to improve ulcerative colitis treatments

Ulcerative colitis (UC) is a chronic, relapsing inflammatory bowel disease in which persistent mucosal inflammation damages the epithelial barrier.

3 Nov 2026

New initiative provides lung cancer screening for Illinois firefighters

Northwestern Medicine will screen more than 300 firefighters from Chicago and DeKalb, Illinois, for lung cancer through its innovative Lung Health Center at the Canning Thoracic Institute, continuing efforts to detect cancer earlier in populations at increased risk.

3 Nov 2026